Today: 11 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Disney Stock (DIS) Outlook on Dec. 20, 2025: OpenAI Deal, ESPN Streaming Momentum, and Parks Pricing Power Put Shares Back in Focus

Disney Stock (DIS) Outlook on Dec. 20, 2025: OpenAI Deal, ESPN Streaming Momentum, and Parks Pricing Power Put Shares Back in Focus

On one hand, the Walt Disney Company’s legacy businesses are still navigating structural pressure: cord-cutting continues to erode the traditional TV bundle, and distribution disputes remain a very real headline risk. On the other, Disney is showing the kind of operating leverage investors have been demanding for years: streaming profitability is improving, Experiences remains a profit engine, and management is leaning into technology as both a product feature and an efficiency lever.
21 December 2025
·
Gold Price Today (December 20, 2025): MCX Gold Rebounds, Silver Slips After Record High — Latest 24K, 22K Rates in Delhi, Mumbai, Jaipur and Udaipur

Gold Price Today (December 20, 2025): MCX Gold Rebounds, Silver Slips After Record High — Latest 24K, 22K Rates in Delhi, Mumbai, Jaipur and Udaipur

Meta description: Gold and silver prices remained volatile on December 20, 2025. MCX gold futures recovered sharply, while silver cooled off after touching a fresh record. Here’s a detailed, city-wise look at today’s 24K and 22K gold rates, silver prices, and what’s driving the bullion market.
21 December 2025
··
NextEra Energy Stock (NEE) in Focus: AI Data Center Deals, 2026 Earnings Outlook, and Wall Street Price Targets — Dec. 20, 2025

NextEra Energy Stock (NEE) in Focus: AI Data Center Deals, 2026 Earnings Outlook, and Wall Street Price Targets — Dec. 20, 2025

NextEra Energy, Inc. is ending 2025 with a familiar role—and a new narrative. For years, investors have treated NextEra as a premium “growth utility,” built on Florida Power & Light’s regulated stability and NextEra Energy Resources’ renewables scale. In December, that story expanded into something broader: power for AI and hyperscale data centers—and the infrastructure required to deliver it reliably.
21 December 2025
·
Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

Vertex Pharmaceuticals (VRTX) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025: Casgevy Pediatric Data, Kidney Pipeline Momentum, and Journavx Launch Watch

December 20, 2025 — Vertex Pharmaceuticals Incorporated heads into the year’s final stretch with investors focused on a familiar question: can the biotech’s next wave of launches and late-stage programs begin to meaningfully diversify a cystic fibrosis business that has dominated its revenue for more than a decade?
21 December 2025
··
Coinbase (COIN) Stock News Today (Dec. 20, 2025): “Everything Exchange” Push, Prediction-Market Lawsuits, and Wall Street Forecasts

Coinbase (COIN) Stock News Today (Dec. 20, 2025): “Everything Exchange” Push, Prediction-Market Lawsuits, and Wall Street Forecasts

Coinbase Global, Inc. is ending the week in the spotlight after a rapid sequence of catalysts reshaped the near-term narrative around the stock: a major product rollout that brings stock trading and prediction markets into the main Coinbase app, new legal fights over whether states can restrict those prediction markets, and fresh analyst coverage framing Coinbase’s ambition to become a multi-asset “everything exchange.” Investing.com+3Coinbase+3Reuters+3
20 December 2025
··
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

December 20, 2025 — Amicus Therapeutics, Inc. has abruptly shifted from a “rare-disease growth story” to a merger-arbitrage stock after BioMarin Pharmaceutical announced a definitive, all-cash acquisition valued at roughly $4.8 billion. The headline number for shareholders: $14.50 per share in cash, a premium of about 33% to Amicus’ prior close. Reuters+2BioMarin Corporate+2
20 December 2025
···
Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining Company stock is ending 2025 in the spotlight—riding a historic surge in silver prices, fresh company catalysts in Nevada, and a looming index event that could reshape near-term trading flows. As of Dec. 20, 2025, HL is around $19.67 after a volatile day that pushed above $20.50. StockInvest
20 December 2025
··
1 … 713 714 715 716 717 … 880

Stock Market Today

  • Bitcoin Halving History Puts $300K-$500K Targets in Doubt, Points to Slower Growth
    July 11, 2026, 12:22 AM EDT. Peter Brandt and Bernstein analysts see bitcoin possibly hitting $300,000 to $500,000, pointing to fresh demand from spot ETFs. But halving cycles tell a different story: past peaks rose from $266 in 2013 to almost $69,000 in 2021. The projected 2025 peak is $126,000, continuing a trend of lower multiples each time. Gains shrink every cycle, making explosive runs less likely. Bitcoin is maturing, and its market cap is getting bigger. More capital is needed now to move the price. ETFs and other Wall Street-style products are making bitcoin trade with less volatility, more like mainstream financial assets, and the days of wild price swings may be fading.
Go toTop